You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Become a Subscriber
Subscribe•You
- manufacturingchemist.com (1 User) - access to exclusive content.
- Manufacturing Chemist magazine (both print and digital).
- Discounted tickets to attend relevant conferences.
Subscribe•Your Team
- manufacturingchemist.com (multi-user) - access to exclusive content.
- Manufacturing Chemist magazine (both print and digital).
- Discounted group tickets to attend relevant conferences.
Get access to subscriber exclusive breaking news, interviews, technical reviews and long form features, covering the entire industry.
More stories
Manufacturing
Shilpa Medicare signs commercial biologics manufacturing agreement with NXI Therapeutics
The strategic partnership will see Shilpa provide development and manufacturing support for Swiss-based NXI Therapeutics, positioning it as a lifecycle partner for NXI's immunomodulatory programmes
Sustainability
Merck launches first bio-based HPLC solvent portfolio with lower CO2 emissions than fossil-fuel alternatives
The new patent-pending portfolio of renewable solvents for high-performance liquid chromatography offers replacements for acetonitrile, methanol and ethanol that reduce carbon emissions while maintaining performance
Ingredients
The impact of Brexit on raw materials testing for the pharmaceutical industry (2026 update)
Since the UK departed from the EU, the pharmaceutical regulatory landscape has undergone significant and lasting change; whereas early uncertainty has largely subsided, the system has evolved into a stable but more complex dual framework
Drug Delivery
embecta completes £100m acquisition of UK-based Owen Mumford to bolster drug delivery portfolio
US diabetes care company embecta has finalised its acquisition of Owen Mumford, gaining access to the Aidaptus next-generation auto-injector platform as it accelerates its transition into a broad-based medical supplies company
Research & Development
VoxCell BioInnovation and adMare partner to validate bioprinted vascularised cancer tissue models for antibody therapy development
The pair have announced a research collaboration using VoxCell's human-relevant bioprinted vascularised cancer tissue models to validate a novel antibody-based immune-modulating therapy, as the FDA advances plans to reduce animal testing for monoclonal antibodies through New Approach Methodologies
Regulatory
FDA approves AstraZeneca's FASENRA for hypereosinophilic syndrome
AstraZeneca's FASENRA has received FDA approval for hypereosinophilic syndrome in adults and adolescents aged 12 and above, based on Phase III NATRON trial data showing a 65% reduction in the risk of first HES flare compared to placebo
Finance
Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business
The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex Biopharma to scale its end-to-end biologics platform
Manufacturing
OrganaBio acquires Excellos to create bicoastal cell therapy CDMO
The cell and blood product manufacturer has acquired the operating assets of San Diego-based Excellos, creating a coast-to-coast cell therapy contract development and manufacturing organisation platform spanning multiple US facilities
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing
As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
Featured companies
Biotech Fluidics AB
At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable.
CARBOGEN AMCIS
CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and...
Shimadzu UK
Shimadzu UK provides a broad range of analytical instruments indispensable for research, development, and quality control in a variety of fields
Piramal Pharma Solutions
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life...
Resource Centre
About Manufacturing Chemist
Manufacturing Chemist
Through digital, live and print products, Manufacturing Chemist informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors write breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry from ingredients and packaging to regulation, retail and marketing.
Pharma 5.0
Pharma 5.0 represents a paradigm shift in pharmaceutical manufacturing, paving the way for a future where medications are developed faster, customised to individual patient needs and delivered with uncompromising quality. It is not just about innovation; it is about transforming the way we think about healthcare and ultimately improving the lives of patients around the world.